top
Search terms
Results 1 - 6 of 6 - ordered by :
Ehjcvp

Introduction Non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) have been used in clinical practice for more than a century and are among the most widely used drugs worldwide for the ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Morten Schmidt, Morten Lamberts, Anne-Marie Schjerning Olsen, Emil Fosbøll, Alexander Niessner, Juan Tamargo, Giuseppe Rosano, ...

Date : 01/04/2016 Item size : 461588 bytes
Ehjcvp

In this issue of the journal, Sverre E. Kjeldsen and Giuseppe Mancia comment on the measurement technique for blood pressure (BP) that was used in the important SPRINT study, and they discuss whether ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Stefan Agewall

Date : 01/04/2016 Item size : 103672 bytes
Ehjcvp

Given the burden of cardiovascular disease in patients with diabetes, the focus should shift towards cardiovascular outcome studies designed to evaluate efficacy (i.e. to determine the efficacy of a ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, Faiez Zannad, Wendy Gattis Stough, Raymond J. Lipicky, Juan Tamargo, George L. Bakris, Jeffrey S. Borer, Maria de los Angeles Alonso ...

Date : 01/07/2016 Item size : 285307 bytes
Ehjcvp

Abstract Cardiovascular disease is the leading cause of morbidity and mortality among patients with diabetes, underscoring the importance of choosing anti-diabetic drugs that do not increase ...

European Heart Journal - Cardiovascular Pharmacotherapy, REVIEWS, R. Kumar, D. M. Kerins, T. Walther

Date : 01/01/2016 Item size : 517106 bytes
Ehjcvp

[...]authors contemplating submissions of their research in international peer-reviewed journals are now increasingly turning to the EHJCVP. In this comprehensive work, the authors shed light on ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, Dan Atar

Date : 01/01/2017 Item size : 171743 bytes
Ehjcvp

In recent years, guidance from both the US Food and Drug Administration (FDA)2 and the European Medicines Agency (EMA)3 addressing evaluation of the cardiovascular risk of new antidiabetic drugs for ...

European Heart Journal - Cardiovascular Pharmacotherapy, Editorials, J. Rick Turner, Dilip R. Karnad, Snehal Kothari, Alan Metz, Hitesh Patel, Erica Caveney

Date : 01/01/2017 Item size : 128050 bytes